| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $748.3M | +13.9% |
| Cost of Revenue | $133.5M | +14.6% |
| R&D Expense | $178.4M | +16.6% |
| SG&A Expense | $109.7M | +19.1% |
| Operating Income | $79.2M | -3.9% |
| Interest Expense | $1.7M | +55.0% |
| Pre-tax Income | $82.7M | -6.8% |
| Income Tax | $32.1M | -1.5% |
| Net Income | $50.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $259.0M | -11.5% |
| Short-term Investments | $17.8M | +0.0% |
| Accounts Receivable | $221.2M | -2.2% |
| Current Assets | $519.3M | -7.1% |
| Total Assets | $1.35B | +6.1% |
| Current Liabilities | $121.6M | +17.5% |
| Total Liabilities | $222.8M | +15.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $211.2M | +32.3% |
| Capital Expenditures | $38.5M | +41.9% |
| Investing Cash Flow | -$105.4M | -135.0% |
| Financing Cash Flow | -$143.9M | -11.2% |
| Free Cash Flow | $172.7M | +30.3% |
| -9.9% |
| EPS (Basic) | $0.31 | -6.1% |
| EPS (Diluted) | $0.30 | -6.3% |
| Stockholders' Equity |
| $1.13B |
| +4.4% |